Prostatitis: prevalence, health impact and quality improvement strategies
- PMID: 22876597
Prostatitis: prevalence, health impact and quality improvement strategies
Abstract
Since its identification as a discrete entity, prostatitis has been a crippling and dreadful disease for the males and from then till date it is well recognized that it has continuously eluded the urologists and the practitioners and the patients were generally avoided. But the newer advent in research has changed the concept of the medical management of prostatitis that had been in stagnation for the past many years. The traditional myths related to the disease were continued to be unlighted with improved understanding of the distribution, cause and measures for the management of this disease. From herbal treatment used by the ethnic communities historically to today's modern treatment modules of antimicrobial and anti-inflammatory agents, though not very successful, but has embarked a light of hope in both practitioners and patients for the effective management of this condition, which has negatively affected the normal as well as intimate life of the sufferers. With newer and more widely accepted classification of the disease the practitioners and patients diagnosed with prostatitis now can hope for a better improvement and management of the disease. The present study tries to encompass the important and useful work reported by several workers and progress in the effective management of this awful condition.
Similar articles
-
Prostatitis-like symptoms: diagnosis and management in a Malaysian primary care population.Urol Int. 2009;82(1):32-7. doi: 10.1159/000176022. Epub 2009 Jan 20. Urol Int. 2009. PMID: 19172094
-
Bacterial prostatitis.Urol Clin North Am. 2008 Feb;35(1):23-32; v. doi: 10.1016/j.ucl.2007.09.008. Urol Clin North Am. 2008. PMID: 18061021 Review.
-
Identification, pharmacologic considerations, and management of prostatitis.Am J Geriatr Pharmacother. 2011 Feb;9(1):37-48. doi: 10.1016/j.amjopharm.2011.02.005. Am J Geriatr Pharmacother. 2011. PMID: 21459307 Review.
-
[Prostanorm in the treatment of chronic non-infectious prostatitis].Ter Arkh. 2005;77(10):65-8. Ter Arkh. 2005. PMID: 16320689 Russian.
-
Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study.J Urol. 2007 Dec;178(6):2411-5; discussion 2415. doi: 10.1016/j.juro.2007.08.046. Epub 2007 Oct 15. J Urol. 2007. PMID: 17937946
Cited by
-
Registered Drug Packs of Antimicrobials and Treatment Guidelines for Prostatitis: Are They in Accordance?Healthcare (Basel). 2022 Jun 22;10(7):1158. doi: 10.3390/healthcare10071158. Healthcare (Basel). 2022. PMID: 35885685 Free PMC article.
-
A systematic review of cross-cultural adaptation of the National Institutes of Health Chronic Prostatitis Symptom Index.Health Qual Life Outcomes. 2021 May 31;19(1):159. doi: 10.1186/s12955-021-01796-8. Health Qual Life Outcomes. 2021. PMID: 34059073 Free PMC article.
-
The risk factors related to the severity of pain in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome.BMC Urol. 2020 Oct 7;20(1):154. doi: 10.1186/s12894-020-00729-9. BMC Urol. 2020. PMID: 33028277 Free PMC article.
-
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2019 Oct 6;10(10):CD012552. doi: 10.1002/14651858.CD012552.pub2. Cochrane Database Syst Rev. 2019. PMID: 31587256 Free PMC article. Review.
-
Comparison of 3 assessment modes of acupuncture effect on patients with chronic prostatitis/chronic pelvic pain syndrome: A study protocol for a randomized controlled trial.Medicine (Baltimore). 2018 Oct;97(42):e12887. doi: 10.1097/MD.0000000000012887. Medicine (Baltimore). 2018. PMID: 30335011 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
